Company: SMNR
Filing Date: 2025-07-23
Form Type: S-4/A
Source: 0001193125-25-163401
Chunk: 352

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-23
Form: S-4/A
Chunk 352
---
501 |
| Gross Profit(3)             |     | $      |          — |   |     | $      |           — |   |     | $      |           — |   |     | $      | (26,512,910 | ) |     | $      | 214,600,284 |     | $      |   522,122,880 |     | $      | 2,168,514,643 |     | $      | 2,602,368,740 |     | $      | 2,744,467,295 |     | $      | 2,845,750,307 |
| Total Operating Expenses(4) |     | $      |  7,921,964 |   |     | $      |  20,952,765 |   |     | $      |  22,648,280 |   |     | $      |  34,840,527 |   |     | $      |  30,272,191 |     | $      |    27,605,530 |     | $      |    40,678,094 |     | $      |    45,445,903 |     | $      |    49,990,493 |     | $      |    54,989,543 |
| Operating Income (loss)(5)  |     | $      | (7,921,964 | ) |     | $      | (20,952,765 | ) |     | $      | (22,648,280 | ) |     | $      | (61,353,438 | ) |     | $      | 184,328,093 |     | $      |   484,517,349 |     | $      | 2,127,836,549 |     | $      | 2,556,922,837 |     | $      | 2,694,476,801 |     | $      | 2,790,760,764 |

|                             |     | FY2034 |               |     | FY2035 |               |     | FY2036 |               |     | FY2037 |               |     | FY2038 |               |     | FY2039 |               |     | FY2040 |               |     | FY2041 |               |     | FY2042 |               |     | FY2043 |               |
|